These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36243484)

  • 1. Saphenous Vein Graft Intervention.
    Bharadwaj AS; Mamas MA
    Interv Cardiol Clin; 2022 Oct; 11(4):383-391. PubMed ID: 36243484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts.
    Cicek D; Doven O; Pekdemir H; Camsari A; Akkus NM; Cin GV; Parmaksiz T; Katircibasi T
    Jpn Heart J; 2004 Jul; 45(4):561-71. PubMed ID: 15353867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention.
    Pellicano M; Floré V; Barbato E; De Bruyne B
    BMC Cardiovasc Disord; 2018 Jun; 18(1):122. PubMed ID: 29921223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saphenous vein graft intervention.
    Lee MS; Park SJ; Kandzari DE; Kirtane AJ; Fearon WF; Brilakis ES; Vermeersch P; Kim YH; Waksman R; Mehilli J; Mauri L; Stone GW
    JACC Cardiovasc Interv; 2011 Aug; 4(8):831-43. PubMed ID: 21851895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!
    Hall AB; Brilakis ES
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E193-E194. PubMed ID: 30770658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Xenogiannis I; Zenati M; Bhatt DL; Rao SV; Rodés-Cabau J; Goldman S; Shunk KA; Mavromatis K; Banerjee S; Alaswad K; Nikolakopoulos I; Vemmou E; Karacsonyi J; Alexopoulos D; Burke MN; Bapat VN; Brilakis ES
    Circulation; 2021 Aug; 144(9):728-745. PubMed ID: 34460327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
    Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW
    J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current percutaneous treatment strategies for saphenous vein graft disease.
    Marmagkiolis K; Grines C; Bilodeau L
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
    Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.